A high-throughput assay for the measurement of uropathogenic Escherichia coli attachment to urinary bladder cells

International Journal of Experimental Pathology

Volumn 97, Issue 2, 2016, Pages 194-201

  García Méndez, Karellen Beren ^a,b   Bragagnolo, Gabriel ^a,b   O'Callaghan, David ^a,b   Lavigne, Jean Philippe ^a,b,c   Keriel, Anne ^a,b  

^a INSERM   (France)

^b UNIV MONTPELLIER   (France)

^c DEPARTMENT OF NEUROLOGY   (France)

Author keywords

adhesion; Escherichia coli; ExPEC; flow cytometry; screening; UPEC; urinary tract infections

Indexed keywords

ADHESIN; CRANBERRY EXTRACT; PROANTHOCYANIDIN; VIRULENCE FACTOR;

ARTICLE; BACTERIAL STRAIN; BACTERIUM ADHERENCE; BACTERIUM ISOLATE; BLADDER EPITHELIUM; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; FLOW CYTOMETRY; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN CELL; IN VITRO STUDY; MEASUREMENT; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; URINARY TRACT INFECTION; UROPATHOGENIC ESCHERICHIA COLI;

EID: 84977480931     PISSN: 09599673     EISSN: 13652613     Source Type: Journal    
DOI: 10.1111/iep.12181     Document Type: Article

References (39)

1. Anderson G.G., Palermo J., Schilling J.D., Roth R., Heuser J. & Hultgren S.J. (2003) Intracellular bacterial biofilm-like pods in urinary tract infections. Science 301, 105–107.
2. Bien J., Sokolova O. & Bozko P. (2012) Role of uropathogenic Escherichia coli virulence factors in development of urinary tract infection and kidney damage. Int. J. Nephrol. 2012, 681473.
3. Brumbaugh A.R. & Mobley H.L. (2012) Preventing urinary tract infection: progress toward an effective Escherichia coli vaccine. Expert Rev. Vaccines 11, 663–676.
4. Dale A.P. & Woodford N. (2015) Extra-intestinal pathogenic Escherichia coli (ExPEC): disease, carriage and clones. J. Infect. 71, 615–626.
5. Dhakal B.K., Kulesus R.R. & Mulvey M.A. (2008) Mechanisms and consequences of bladder cell invasion by uropathogenic Escherichia coli. Eur. J. Clin. Invest. 38(Suppl 2), 2–11.
6. Dielubanza E.J. & Schaeffer A.J. (2011) Urinary tract infections in women. Med. Clin. N.A. 95, 27–41.
7. Flatau G., Lemichez E., Gauthier M. et al. (1997) Toxin-induced activation of the G protein p21 Rho by deamidation of glutamine. Nature 387, 729–733.
8. Flores-Mireles A.L., Walker J.N., Caparon M. & Hultgren Scott J. (2015) Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nat. Rev. Microbiol. 13, 269–284.
9. Foxman B. (2003) Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Dis. Mon. 49, 53–70.
10. Greene S.E., Hibbing M.E., Janetka J., Chen S.L., Hultgren S.J. (2015) Human urine decreases function and expression of Type 1 pili in uropathogenic Escherichia coli. MBio 6, e00820.
11. Griebling T.L. (2007) Urinary tract infection in women. Urologic Diseases in America. NIH Pub. No. 07-5512, pp. 587–620 (eds M.S. Litwin, C.S. Saigal), Washington, DC: US GPO.
12. Gupta K., Hooton T.M. & Stamm W.E. (2001) Increasing antimicrobial resistance and the management of uncomplicated community-acquired urinary tract infections. Ann. Intern. Med. 135, 41–50.
13. Gupta K., Chou M.Y., Howell A., Wobbe C., Grady R. & Stapleton A.E. (2007) Cranberry products inhibit adherence of P-Fimbriated Escherichia coli to primary cultured bladder and vaginal epithelial cells. J. Urol. 177, 2357–2360.
14. Gupta A., Dwivedi M., Mahdi A.A., Gowda G.A.N., Khetrapal C.L. & Bhandari M. (2012) Inhibition of adherence of multi-drug resistant E. coli by proanthocyanidin. Urol. Res. 40, 143–150.
15. Hannan T.J., Totsika M., Mansfield K.J., Moore K.H., Schembri M.A. & Hultgren S.J. (2012) Host-pathogen checkpoints and population bottlenecks in persistent and intracellular uropathogenic Escherichia coli bladder infection. FEMS Microbiol. Rev. 36, 616–648.
16. Howell A.B., Botto H., Combescure C. et al. (2010) Dosage effect on uropathogenic Escherichia coli anti-adhesion activity in urine following consumption of cranberry powder standardized for proanthocyanidin content: a multicentric randomized double blind study. BMC Infect. Dis. 10, 94.
17. Hunstad D.A. & Justice S.S. (2010) Intracellular lifestyles and immune evasion strategies of uropathogenic Escherichia coli. Annu. Rev. Microbiol. 64, 203–221.
18. Island M.D., Cui X., Foxman B. et al. (1998) Cytotoxicity of hemolytic, cytotoxic necrotizing factor 1-positive and -negative Escherichia coli to human T24 bladder cells. Infect. Immun. 66, 3384–3389.
19. Kadhum H.J., Finlay D., Rowe M.T., Wilson I.G. & Ball H.J. (2008) Occurrence and characteristics of cytotoxic necrotizing factors, cytolethal distending toxins and other virulence factors in Escherichia coli from human blood and faecal samples. Epidemiol. Infect. 136, 752–760.
20. Kahlmeter G. (2003) An international survey of the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections: the ECO.SENS Project. J. Antimicrob. Chemother. 51, 69–76.
21. Kakkanat A., Totsika M., Schaale K. et al. (2015) The role of H4 flagella in Escherichia coli ST131 virulence. Sci. Rep. 5, 16149.
22. Kaper J.B., Nataro J.P. & Mobley H.L. (2004) Pathogenic Escherichia coli. Nat. Rev. Microbiol. 2, 123–140.
23. Kimble L.L., Mathison B.D., Kaspar K.L., Khoo C. & Chew B.P. (2014) Development of a fluorometric microplate antiadhesion assay using uropathogenic Escherichia coli and human uroepithelial cells. J. Nat. Prod. 77, 1102–1110.
24. Lane D.R. & Takhar S.S. (2011) Diagnosis and management of urinary tract infection and pyelonephritis. Emerg. Med. Clin. North Am. 29, 539–552.
25. Langermann S. & Ballou W.R. (2001) Vaccination utilizing the FimCH complex as a strategy to prevent Escherichia coli urinary tract infections. J. Infect. Dis. 183, S84–S86.
26. Lim J.K., Gunther N.W. 4th, Zhao H., Johnson D.E., Keay S.K. & Mobley H.L. (1998) In vivo phase variation of Escherichia coli type 1 fimbrial genes in women with urinary tract infection. Infect. Immun. 66, 3303–3310.
27. Martinez J.J., Mulvey M.A., Schilling J.D., Pinkner J.S. & Hultgren S.J. (2000) Type 1 pilus-mediated bacterial invasion of bladder epithelial cells. EMBO J. 19, 2803–2812.
28. Mulvey M.A. (2002) Adhesion and entry of uropathogenic Escherichia coli. Cell. Microbiol. 4, 257–271.
29. Mulvey M.A., Lopez-Boado Y.S., Wilson C.L. et al. (1998) Induction and evasion of host defenses by type 1-piliated uropathogenic Escherichia coli. Science 282, 1494–1497.
30. Nicolle L.E. (2008) Uncomplicated urinary tract infection in adults including uncomplicated pyelonephritis. Urol. Clin. North Am. 35, 1–12.
31. Poolman J.T. & Wacker M. (2016) Extraintestinal Pathogenic Escherichia coli, a common human pathogen: challenges for vaccine development and progress in the field. J. Infect. Dis. 213, 6–13.
32. Rafsanjany N., Lechtenberg M., Petereit F. & Hensel A. (2013) Antiadhesion as a functional concept for protection against uropathogenic Escherichia coli: in vitro studies with traditionally used plants with antiadhesive activity against uropathognic Escherichia coli. J. Ethnopharmacol. 145, 591–597.
33. Rafsanjany N., Senker J., Brandt S., Dobrindt U. & Hensel A. (2015) In vivo consumption of cranberry exerts ex vivo antiadhesive activity against FimH-dominated uropathogenic Escherichia coli: a combined in vivo, ex vivo, and in vitro study of an extract from Vaccinium macrocarpon. J. Agric. Food Chem. 63, 8804–8818.
34. Scharenberg M., Abgottspon D., Cicek E. et al. (2011) A flow cytometry-based assay for screening FimH antagonists. Assay Drug Dev. Technol. 9, 455–464.
35. Scholes D., Hooton T.M., Roberts P.L., Gupta K., Stapleton A.E. & Stamm W.E. (2005) Risk factors associated with acute pyelonephritis in healthy women. Ann. Intern. Med. 142, 20–27.
36. Subashchandrabose S., Hazen T.H., Brumbaugh A.R. et al. (2014) Host-specific induction of Escherichia coli fitness genes during human urinary tract infection. Proc. Natl Acad. Sci. USA 111, 18327–18332.
37. Vergunst A.C., Meijer A.H., Renshaw S.A. & O'Callaghan D. (2010) Burkholderia cenocepacia creates an intramacrophage replication niche in zebrafish embryos, followed by bacterial dissemination and establishment of systemic infection. Infect. Immun. 78, 1495–1508.
38. Wang C.H., Fang C.C., Chen N.C. et al. (2012) Cranberry-containing products for prevention of urinary tract infections in susceptible populations. Arch. Intern. Med. 172, 988–996.
39. Wiles T.J., Kulesus R.R. & Mulvey M.A. (2008) Origins and virulence mechanisms of uropathogenic Escherichia coli. Exp. Mol. Pathol. 85, 11–19.